Literature DB >> 12869673

Parenteral methotrexate should be given before biological therapy.

S J Bingham, M H Buch, S Lindsay, A Pollard, J White, P Emery.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12869673     DOI： 10.1093/rheumatology/keg246

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

1.  [Methotrexate: advantages of subcutaneous administration].

Authors:  K Krüger
Journal:  Z Rheumatol       Date:  2008-07       Impact factor: 1.372

Review 2.  Optimizing Methotrexate Treatment in Rheumatoid Arthritis: The Case for Subcutaneous Methotrexate Prior to Biologics.

Authors:  Poonam Sharma; David G I Scott
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

3.  Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis.

Authors:  J Wegrzyn; P Adeleine; P Miossec
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

4.  Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting.

Authors:  Eric Senbel; Sonia Tropé; Hélène Herman-Demars; Elena Zinovieva; Agnès Courbeyrette; Pierre Clerson; Yann Fardini; René-Marc Flipo
Journal:  Patient Prefer Adherence       Date:  2021-04-14       Impact factor: 2.711

5.  Patient's experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis.

Authors:  J R Curtis; F Xie; D Mackey; N Gerber; A Bharat; T Beukelman; K G Saag; L Chen; B Nowell; S Ginsberg
Journal:  BMC Musculoskelet Disord       Date:  2016-09-26       Impact factor: 2.362
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.